Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Icahn Enterprises, L.P. (IEP)’s Carl Icahn Wants to Show You the Money

When activists clash!

While Carl Icahn is best known for his widely publicized battles with the boards of Netflix, Inc. (NASDAQ:NFLX), The Clorox Company (NYSE:CLX) and Biogen Idec Inc. (NASDAQ:BIIB), he has also clashed with other activist investors on multiple occasions.

Icahn’s most recent foe is William Ackman, the activist investor who is waging a personal war against Herbalife Ltd. (NYSE:HLF).

William Ackman has claimed that Herbalife, a multi-level marketer of nutritional and skincare products, is a ‘pyramid scheme’ running on inflated numbers. Ackman has been so certain of his accusations that he once held a three-hour presentation denouncing the company, and launched a web page dedicated to his arguments. Icahn disagrees with Ackman and believes that the company has long-term growth potential.

Both men are certainly putting their money where their mouths are. Ackman’s hedge fund, Pershing Square Capital, disclosed that it was shorting approximately $1 billion in Herbalife shares. Icahn responded by buying a 13% stake in the distressed company, which has a total market value of $4 billion.

Regardless of Herbalife’s financial honesty or the sustainability of its multi-level marketing system, the company’s numbers are financially strong, as seen it the chart below.

HLF Revenue TTM data by YCharts

What’s more, Herbalife recently beat earnings estimates handily for its fourth quarter, posting record growth. It also upped its guidance for fiscal 2013.

Yet I firmly believe Carl Icahn’s investment has less to do with Herbalife’s fundamentals and more about forcing shorts mimicking Ackman, a widely followed investor, to panic and cover their positions.

‘Short squeezes’ – where traders shorting the stock rush to repurchase, or cover, their positions, often cause huge rallies. Indeed, news of Icahn’s initial investment initially caused the stock to rally more than 20%.

The Foolish Bottom Line

In the end, investing in holdings conglomerates such as Icahn Enterprises and Berkshire Hathaway have less to do with macro factors and more about your faith in the CEO. Just as some mutual and hedge funds are actively managed by star portfolio managers, Carl Icahn and Warren Buffett have their own approaches to maximizing shareholder value. However, for dividend investors interested in following one of these star investors, Icahn Enterprises, now offering nearly 5% in dividends, is clearly a more attractive choice than Berkshire Hathaway, which does not pay one at all.

The article Carl Icahn Wants to Show You the Money originally appeared on Fool.com and is written by Leo Sun.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!